# FDA Inspection 725013 - Raritan Pharmaceuticals, Inc. - May 18, 2011

Source: https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/b722055c-307e-494d-af48-5f4110ad0bd2
Source feed: FDA_Inspections

> FDA Inspection 725013 for Raritan Pharmaceuticals, Inc. on May 18, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 725013
- Company Name: Raritan Pharmaceuticals, Inc.
- Inspection Date: 2011-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1250227 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/1a844f99-5473-4890-a8bf-2c8de0080187)
- [FDA Inspection 1037112 - 2018-01-08](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/f275a0be-8cda-446f-9c15-5566f69959dc)
- [FDA Inspection 995165 - 2016-10-20](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/779fe977-f104-48a2-84ec-2f8ccae976e3)
- [FDA Inspection 969785 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/4e1f0a76-f5de-436c-9de0-36541b294bdc)
- [FDA Inspection 799355 - 2012-09-19](https://www.keypedia.com/records/fda_inspections/raritan-pharmaceuticals-inc/af765194-be49-48aa-836e-424e9af61645)

Company: https://www.keypedia.com/companies/raritan-pharmaceuticals-inc/31d76ce5-e5b2-4f61-b7b5-daa1a81f7cf0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c